Company research
iTeos Therapeutics, Inc.
CIK 1808865Updated Sep 27, 2026
Filing activity
Latest filing
50 filings on record · SCHEDULE 13G/A, 15-12G, EFFECT, SCHEDULE 13D/A, 4, S-8 POS.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 686,976,000Source | 667,588,000Source | 754,991,000Source | 884,712,000Source |
| Property, Plant and Equipment, NetUSD | 4,895,000Source | 4,696,000Source | 2,121,000Source | 2,072,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 142,131,000Source | 251,177,000Source | 284,803,000Source | 848,537,000Source |
| Assets, CurrentUSD | 509,539,000Source | 550,652,000Source | 628,298,000Source | 874,713,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 11,200,000Source | 12,236,000Source | 12,701,000Source | 14,086,000Source |
| Operating Lease, Right-of-Use AssetUSD | 5,089,000Source | 6,036,000Source | 4,652,000Source | 5,329,000Source |
| Other Assets, NoncurrentUSD | 894,000Source | 883,000Source | 332,000Source | 296,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 96,682,000Source | 92,360,000Source | 91,659,000Source | 331,892,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 37,000Source | 36,000Source | 36,000Source | 35,000Source |
| Additional Paid in CapitalUSD | 616,037,000Source | 463,799,000Source | 435,665,000Source | 413,180,000Source |
| Retained Earnings (Accumulated Deficit)USD | -9,781,000Source | 124,633,000Source | 237,275,000Source | 140,623,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -15,999,000Source | -13,240,000Source | -9,644,000Source | -1,018,000Source |
| Stockholders' Equity Attributable to ParentUSD | 590,294,000Source | 575,228,000Source | 663,332,000Source | 552,820,000Source |
| Liabilities and EquityUSD | 686,976,000Source | 667,588,000Source | 754,991,000Source | 884,712,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 40,360,000Source | 40,014,000Source | 42,000,000Source | 304,124,000Source |
| Operating Lease, Liability, CurrentUSD | 1,336,000Source | 1,251,000Source | 836,000Source | 770,000Source |
| Accounts Payable, CurrentUSD | 8,503,000Source | 11,293,000Source | 7,662,000Source | 5,145,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,760,000Source | 4,807,000Source | 3,837,000Source | 4,571,000Source |
| Other Liabilities, NoncurrentUSD | — | — | 0Source | 33,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | 7,058,000Source | 19,727,000Source | 17,157,000Source |
| Deferred Tax Liabilities, NetUSD | 0Source | 0Source | 0Source | 0Source |
| Short-term InvestmentsUSD | 352,517,000Source | 280,739,000Source | 328,359,000Source | — |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 29,941,000Source | 27,021,000Source | 21,561,000Source | 13,794,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -2,446,000Source | 3,036,000Source | 2,761,000Source | 2,280,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -98,181,000Source | -103,756,000Source | -111,193,000Source | 513,140,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -131,151,000Source | 72,658,000Source | -446,062,000Source | -1,242,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,633,000Source | 2,966,000Source | 938,000Source | 1,181,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 122,241,000Source | 1,113,000Source | 1,984,000Source | 3,659,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -109,021,000Source | -33,587,000Source | -563,797,000Source | 512,381,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 142,430,000Source | 251,451,000Source | 285,038,000Source | 848,835,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 4,032,000Source | 6,816,000Source | 22,816,000Source | 32,019,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 29,941,000Source | 27,021,000Source | 21,561,000Source | 13,794,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 2,063,000Source | — | — | — |
| General and Administrative ExpenseUSD | 49,081,000Source | 50,396,000Source | 43,947,000Source | 40,505,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Income Tax Expense (Benefit)USD | 14,072,000Source | 3,612,000Source | 52,084,000Source | 41,943,000Source |
| Net Income (Loss) Attributable to ParentUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Operating ExpensesUSD | 194,528,000Source | 163,696,000Source | 141,306,000Source | 99,874,000Source |
| Other Nonoperating Income (Expense)USD | 3,111,000Source | 4,083,000Source | 7,788,000Source | 1,382,000Source |
| Payments to Acquire InvestmentsUSD | 520,801,000Source | 290,541,000Source | 445,004,000Source | — |
| Proceeds from Issuance of Common StockUSD | 2,724,000Source | 1,113,000Source | 925,000Source | 2,943,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 35,000,000Source | 12,595,000Source | 267,630,000Source | 344,775,000Source |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 35,000,000Source | 12,595,000Source | 267,630,000Source | 344,775,000Source |
| Operating Income (Loss)USD | -159,528,000Source | -151,101,000Source | 126,324,000Source | 244,901,000Source |
| Other Nonoperating Income (Expense)USD | 3,111,000Source | 4,083,000Source | 7,788,000Source | 1,382,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -120,342,000Source | -109,030,000Source | 148,736,000Source | 256,464,000Source |
| Income Tax Expense (Benefit)USD | 14,072,000Source | 3,612,000Source | 52,084,000Source | 41,943,000Source |
| Net Income (Loss) Attributable to ParentUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Earnings Per Share, BasicUSD per share | -3.32Source | -3.15Source | 2.72Source | 6.1Source |
| Earnings Per Share, DilutedUSD per share | -3.32Source | -3.15Source | 2.56Source | 5.68Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 40,474,385Source | 35,763,520Source | 35,552,025Source | 35,181,383Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 40,474,385Source | 35,763,520Source | 37,766,507Source | 37,774,790Source |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 1,238,000Source | 898,000Source | 803,000Source | 603,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 2,063,000Source | — | — | — |
| General and Administrative ExpenseUSD | 49,081,000Source | 50,396,000Source | 43,947,000Source | 40,505,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -79,553,000Source | -70,172,000Source | -72,940,000Source | -47,242,000Source |
| Interest Income, OtherUSD | 30,872,000Source | 31,774,000Source | 11,361,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -134,414,000Source | -112,642,000Source | 96,652,000Source | 214,521,000Source |
| Operating ExpensesUSD | 194,528,000Source | 163,696,000Source | 141,306,000Source | 99,874,000Source |
| Research and Development ExpenseUSD | 145,447,000Source | 113,300,000Source | 97,359,000Source | 59,369,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 35,000,000Source | 12,595,000Source | 267,630,000Source | 344,775,000Source |